323 is the total number of securities First Light Asset Management, LLC has owned. The longest First Light Asset Management, LLC has owned a single stock is 43 quarters.
Period | Weighting | Quarter | |||||||
---|---|---|---|---|---|---|---|---|---|
Ticker | Name | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
ATRC | ATRICURE INC | 43 | 43 | 2.29% | 5.71% | 9.73% | Q4 2013 | Q2 2024 | 43 |
NEO | NEOGENOMICS INC | 43 | 43 | 0.86% | 5.40% | 10.55% | Q4 2013 | Q2 2024 | 43 |
SNY | SANOFI-SYNTHELABO | 41 | 41 | 0.02% | 0.12% | 1.92% | Q4 2013 | Q4 2023 | 41 |
JNJ | JOHNSON & JOHNSON | 41 | 41 | 0.02% | 0.10% | 0.30% | Q4 2013 | Q4 2023 | 41 |
PFE | PFIZER INC | 39 | 39 | 0.02% | 0.20% | 0.89% | Q4 2013 | Q2 2023 | 39 |
BMRN | BIOMARIN PHARMACEUTICA... | 27 | 10 | 0.41% | 0.96% | 1.57% | Q4 2013 | Q4 2023 | 37 |
NVS | NOVARTIS AG-SPONSORED ADR | 29 | 5 | 0.02% | 0.14% | 0.41% | Q4 2013 | Q4 2023 | 34 |
OMCL | OMNICELL INC | 13 | 8 | 1.32% | 3.54% | 7.69% | Q4 2013 | Q3 2023 | 33 |
QDEL | QUIDEL CORP | 33 | 33 | 0.42% | 1.23% | 3.69% | Q4 2013 | Q4 2021 | 33 |
MODN | MODEL N INC | 32 | 32 | 1.49% | 4.60% | 9.04% | Q2 2016 | Q1 2024 | 32 |
LHCG | LHC GROUP INC | 29 | 29 | 0.15% | 1.41% | 4.55% | Q2 2015 | Q2 2022 | 29 |
MRK | MERCK N CO INC NEW | 29 | 29 | 0.03% | 0.12% | 0.28% | Q4 2013 | Q4 2020 | 29 |
OXFD | OXFORD IMMUNOTEC GLOBA... | 28 | 28 | 1.71% | 4.14% | 9.35% | Q1 2014 | Q4 2020 | 28 |
HALO | HALOZYME THERAPEUTICS INC | 28 | 28 | 0.40% | 3.52% | 8.13% | Q1 2017 | Q4 2023 | 28 |
ANTM | ELEVANCE HEALTH INC | 15 | 1 | 0.02% | 0.10% | 0.32% | Q4 2014 | Q4 2023 | 28 |
LGND | LIGAND PHARMACEUTICALS... | 27 | 27 | 0.56% | 2.43% | 4.24% | Q4 2013 | Q2 2020 | 27 |
TNDM | TANDEM DIABETES CARE INC | 26 | 26 | 0.86% | 2.72% | 6.53% | Q1 2018 | Q2 2024 | 26 |
LMAT | LEMAITRE VASCULAR INC | 26 | 26 | 0.18% | 1.05% | 3.07% | Q4 2013 | Q1 2020 | 26 |
VRTX | VERTEX PHARMACEUTICALS... | 26 | 26 | 0.64% | 0.93% | 1.28% | Q4 2013 | Q1 2020 | 26 |
UTHR | UNITED THERAPEUTICS CO... | 12 | 2 | 0.02% | 0.29% | 2.08% | Q4 2013 | Q4 2023 | 26 |
ABBV | ABBVIE INC | 24 | 2 | 0.02% | 0.06% | 0.12% | Q4 2016 | Q4 2023 | 26 |
INSM | INSMED INC | 20 | 5 | 0.59% | 2.14% | 3.95% | Q1 2015 | Q2 2024 | 25 |
TECH | BIO TECHNE CORP | 22 | 3 | 0.20% | 1.17% | 2.48% | Q4 2014 | Q4 2023 | 25 |
ALKS | ALKERMES PLC | 24 | 24 | 0.21% | 1.17% | 2.35% | Q4 2013 | Q3 2019 | 24 |
KIDS | ORTHOPEDIATRICS CORP | 24 | 24 | 0.38% | 0.89% | 1.58% | Q1 2018 | Q4 2023 | 24 |
SLP | SIMULATIONS PLUS INC | 24 | 24 | 0.09% | 0.38% | 1.00% | Q3 2018 | Q2 2024 | 24 |
HUM | HUMANA INC | 12 | 1 | 0.03% | 0.18% | 0.53% | Q4 2013 | Q2 2024 | 24 |
ARRY | ARRAY BIOPHARMA INC | 23 | 23 | 0.78% | 3.79% | 7.80% | Q4 2013 | Q2 2019 | 23 |
KRMD | REPRO-MED SYSTEMS INC | 23 | 23 | 0.94% | 2.68% | 9.27% | Q4 2018 | Q2 2024 | 23 |
HSTM | HEALTHSTREAM INC | 23 | 23 | 0.33% | 1.43% | 3.47% | Q4 2013 | Q2 2019 | 23 |
AMGN | AMGEN INC | 11 | 1 | 0.02% | 0.10% | 0.22% | Q1 2014 | Q4 2020 | 23 |
HBIO | HARVARD BIOSCIENCE INC | 22 | 22 | 0.16% | 3.77% | 5.97% | Q1 2014 | Q2 2019 | 22 |
VCYT | VERACYTE INC | 22 | 22 | 0.93% | 1.84% | 3.06% | Q4 2014 | Q1 2020 | 22 |
BLUE | BLUEBIRD BIO INC | 22 | 22 | 0.26% | 1.08% | 1.97% | Q4 2014 | Q1 2020 | 22 |
BMY | BRISTOL-MYERS SQUIBB CO | 12 | 3 | 0.03% | 0.25% | 1.04% | Q4 2013 | Q3 2022 | 22 |
XENT | INTERSECT ENT INC. | 21 | 21 | 1.33% | 2.55% | 4.37% | Q1 2017 | Q1 2022 | 21 |
SIBN | SI-BONE INC | 21 | 21 | 1.00% | 2.44% | 5.09% | Q2 2019 | Q2 2024 | 21 |
RARE | ULTRAGENYX PHARMACEUTI... | 21 | 21 | 0.85% | 2.15% | 3.81% | Q2 2019 | Q2 2024 | 21 |
CDXS | CODEXIS INC | 21 | 21 | 0.50% | 1.74% | 3.08% | Q2 2017 | Q2 2022 | 21 |
IMMU | IMMUNOMEDICS INC | 20 | 20 | 1.06% | 4.10% | 13.75% | Q4 2015 | Q3 2020 | 20 |
NXTM | NXSTAGE MEDICAL INC | 20 | 20 | 0.45% | 2.00% | 3.79% | Q1 2014 | Q4 2018 | 20 |
HCAT | HEALTH CATALYST INC | 20 | 20 | 0.05% | 1.63% | 3.13% | Q3 2019 | Q2 2024 | 20 |
STRM | STREAMLINE HEALTH SOLU... | 20 | 20 | 0.01% | 1.36% | 2.90% | Q4 2013 | Q3 2018 | 20 |
ENZ | ENZO BIOCHEM INC | 19 | 19 | 0.12% | 2.42% | 4.31% | Q1 2014 | Q3 2018 | 19 |
CELG | CELGENE CORP | 19 | 19 | 0.18% | 0.33% | 0.70% | Q4 2013 | Q2 2018 | 19 |
BDX | BECTON DICKINSON & CO | 11 | 8 | 0.03% | 0.15% | 0.27% | Q1 2014 | Q3 2022 | 19 |
SPNE | SEASPINE HOLDINGS CORP | 17 | 17 | 2.80% | 5.48% | 7.51% | Q4 2018 | Q4 2022 | 17 |
IONS | IONIS PHARMACEUTICALS INC | 16 | 1 | 0.41% | 2.05% | 6.45% | Q3 2016 | Q4 2020 | 17 |
TLGT | TELIGENT INC | 17 | 17 | 0.09% | 1.74% | 3.72% | Q4 2015 | Q4 2019 | 17 |
OPRX | OPTIMIZERX CORP | 17 | 17 | 0.55% | 1.54% | 2.86% | Q2 2020 | Q2 2024 | 17 |
IHI | ISHARES US MEDICAL DEV... | 17 | 17 | 0.18% | 0.45% | 2.92% | Q4 2016 | Q4 2020 | 17 |
IBB | ISHARES TR | 17 | 17 | 0.19% | 0.45% | 0.92% | Q4 2016 | Q4 2020 | 17 |
XLV | SELECT SECTOR SPDR TR | 17 | 17 | 0.15% | 0.31% | 0.55% | Q4 2016 | Q4 2020 | 17 |
AXGN | AXOGEN INC | 16 | 16 | 0.15% | 2.01% | 3.51% | Q3 2020 | Q2 2024 | 16 |
SPNC | SPECTRANETICS CORP | 15 | 15 | 1.66% | 3.30% | 6.12% | Q4 2013 | Q2 2017 | 15 |
ATEC | ALPHATEC HOLDINGS INC | 15 | 15 | 0.14% | 3.12% | 7.27% | Q4 2020 | Q2 2024 | 15 |
PRTA | PROTHENA CORP PLC | 14 | 14 | 0.84% | 5.77% | 9.44% | Q4 2020 | Q1 2024 | 14 |
AKRXQ | AKORN INC | 14 | 14 | 3.08% | 5.54% | 8.24% | Q1 2014 | Q2 2017 | 14 |
KRTX | KARUNA THERAPEUTICS INC | 14 | 14 | 1.02% | 2.89% | 7.31% | Q3 2020 | Q4 2023 | 14 |
GMAB | GENMAB AS | 14 | 14 | 0.45% | 1.05% | 2.36% | Q2 2020 | Q3 2023 | 14 |
TAK | TAKEDA PHARMACEUTICAL ... | 11 | 3 | 0.02% | 0.23% | 1.09% | Q1 2019 | Q4 2023 | 14 |
AVTR | AVANTOR INC | 14 | 14 | 0.02% | 0.23% | 1.66% | Q1 2021 | Q2 2024 | 14 |
A | AGILENT TECHNOLOGIES INC | 6 | 1 | 0.02% | 0.11% | 0.25% | Q4 2013 | Q4 2020 | 14 |
BIO | BIO RAD LABS INC | 8 | 1 | 0.02% | 0.09% | 0.15% | Q1 2014 | Q4 2020 | 14 |
DYNT | DYNATRONICS CORP | 14 | 14 | 0.01% | 0.05% | 0.09% | Q2 2017 | Q3 2020 | 14 |
BAX | BAXTER INTL INC | 14 | 14 | 0.02% | 0.03% | 0.04% | Q2 2019 | Q3 2022 | 14 |
RTIX | RTI SURGICAL INC | 13 | 13 | 0.72% | 3.21% | 5.60% | Q4 2013 | Q4 2016 | 13 |
HRTX | HERON THERAPEUTICS INC | 13 | 13 | 1.39% | 2.89% | 5.06% | Q1 2017 | Q1 2020 | 13 |
KRYS | KRYSTAL BIOTECH INC | 13 | 13 | 0.93% | 2.68% | 4.55% | Q2 2020 | Q2 2023 | 13 |
TEVA | TEVA PHARMACEUTICAL IN... | 13 | 13 | 0.64% | 1.77% | 2.99% | Q4 2018 | Q4 2021 | 13 |
PETX | ARATANA THERAPEUTICS INC | 13 | 13 | 0.35% | 0.90% | 2.01% | Q4 2013 | Q4 2016 | 13 |
STJ | ST JUDE MED INC | 13 | 13 | 0.13% | 0.21% | 0.32% | Q4 2013 | Q4 2016 | 13 |
GILD | GILEAD SCIENCES INC | 13 | 13 | 0.02% | 0.03% | 0.05% | Q4 2020 | Q4 2023 | 13 |
BCYC | BICYCLE THERAPEUTICS PLC | 12 | 12 | 1.34% | 2.54% | 4.36% | Q3 2021 | Q2 2024 | 12 |
TEAR | TEARLAB CORP | 11 | 1 | 0.77% | 2.19% | 4.03% | Q4 2013 | Q4 2016 | 12 |
PFMT | PERFORMANT FINL CORP | 12 | 12 | 0.84% | 1.86% | 2.67% | Q3 2021 | Q2 2024 | 12 |
ELGX | ENDOLOGIX INC | 12 | 12 | 0.80% | 1.71% | 2.91% | Q4 2013 | Q3 2016 | 12 |
AXNX | AXONICS MODULATION TEC... | 12 | 12 | 0.54% | 1.51% | 2.26% | Q1 2021 | Q4 2023 | 12 |
CPHD | CEPHEID | 12 | 12 | 0.89% | 1.36% | 1.90% | Q4 2013 | Q3 2016 | 12 |
MYL | MYLAN N V | 7 | 5 | 0.16% | 0.62% | 1.97% | Q1 2015 | Q4 2019 | 12 |
AET | AETNA INC NEW | 12 | 12 | 0.13% | 0.27% | 0.31% | Q4 2013 | Q3 2016 | 12 |
LLY | LILLY ELI & CO | 12 | 12 | 0.19% | 0.22% | 0.24% | Q4 2013 | Q3 2016 | 12 |
CDNA | CAREDX INC | 11 | 11 | 0.95% | 4.37% | 9.58% | Q1 2020 | Q3 2022 | 11 |
CRNX | CRINETICS PHARMACEUTIC... | 11 | 11 | 0.56% | 3.16% | 6.06% | Q4 2021 | Q2 2024 | 11 |
PARAGON 28 INC | 11 | 11 | 0.92% | 2.80% | 4.90% | Q4 2021 | Q2 2024 | 11 | |
PLRX | PLIANT THERAPEUTICS, INC | 11 | 11 | 0.25% | 2.60% | 5.23% | Q4 2021 | Q2 2024 | 11 |
CUTR | CUTERA INC | 11 | 11 | 0.14% | 2.34% | 4.71% | Q1 2021 | Q3 2023 | 11 |
TMDX | TRANSMEDICS GROUP INC | 8 | 3 | 0.07% | 2.11% | 4.79% | Q2 2019 | Q2 2024 | 11 |
ARNA | ARENA PHARMACEUTICALS INC | 11 | 11 | 0.36% | 1.84% | 4.30% | Q2 2019 | Q4 2021 | 11 |
AZN | ASTRAZENECA PLC | 11 | 11 | 0.16% | 0.20% | 0.28% | Q1 2014 | Q3 2016 | 11 |
HRC | HILL-ROM HOLDINGS INC | 6 | 1 | 0.02% | 0.03% | 0.04% | Q3 2018 | Q3 2021 | 11 |
SYNH | SYNEOS HEALTH INC CLASS A | 11 | 11 | 0.02% | 0.03% | 0.05% | Q4 2020 | Q2 2023 | 11 |
SHPG | SHIRE PLC | 10 | 10 | 1.64% | 4.22% | 6.69% | Q3 2016 | Q4 2018 | 10 |
NKTR | NEKTAR THERAPEUTICS | 10 | 10 | 2.00% | 3.89% | 7.00% | Q1 2017 | Q2 2019 | 10 |
ENTL | ENTELLUS MED INC | 10 | 10 | 2.15% | 3.21% | 4.49% | Q3 2015 | Q4 2017 | 10 |
KTWO | K2M GROUP HOLDINGS, INC | 10 | 10 | 1.02% | 1.75% | 2.42% | Q2 2016 | Q3 2018 | 10 |
CLDX | CELLDEX THERAPEUTICS I... | 10 | 10 | 0.40% | 1.59% | 2.41% | Q4 2013 | Q1 2016 | 10 |
ANGO | ANGIODYNAMICS INC | 10 | 10 | 0.66% | 1.37% | 2.10% | Q4 2013 | Q1 2016 | 10 |
AKUMIN INC | 10 | 10 | 0.02% | 0.40% | 0.67% | Q1 2021 | Q2 2023 | 10 | |
MIRO | MIROMATRIX MED INC | 10 | 10 | 0.15% | 0.24% | 0.34% | Q2 2021 | Q3 2023 | 10 |
AGN | ALLERGAN PLC SHS | 6 | 4 | 0.05% | 0.17% | 0.29% | Q2 2015 | Q1 2020 | 10 |
MYGN | MYRIAD GENETICS INC | 10 | 10 | 0.11% | 0.16% | 0.21% | Q1 2014 | Q2 2016 | 10 |
XNCR | XENCOR INC | 9 | 9 | 1.47% | 2.82% | 4.59% | Q4 2017 | Q4 2019 | 9 |
MDCO | MEDICINES COMPANY | 9 | 9 | 1.46% | 1.98% | 2.58% | Q3 2015 | Q3 2017 | 9 |
KROS | KEROS THERAPEUTICS INC | 9 | 9 | 0.45% | 1.96% | 3.16% | Q3 2021 | Q3 2023 | 9 |
CSII | CARDIOVASCULAR SYSTEMS... | 9 | 9 | 0.66% | 1.82% | 3.06% | Q4 2017 | Q4 2019 | 9 |
VAPO | VAPOTHERM INC | 9 | 9 | 0.38% | 1.29% | 2.99% | Q4 2018 | Q4 2020 | 9 |
TPTX | TURNING POINT THERAPEU... | 9 | 9 | 0.37% | 1.14% | 1.98% | Q2 2020 | Q2 2022 | 9 |
MAXCYTE INC | 9 | 9 | 0.32% | 0.71% | 0.90% | Q3 2021 | Q3 2023 | 9 | |
ENDP | ENDO INTL PLC | 9 | 9 | 0.12% | 0.31% | 0.44% | Q1 2014 | Q1 2016 | 9 |
PSCH | INVESCO SMALLCAP HEALT... | 7 | 2 | 0.22% | 0.28% | 0.39% | Q3 2018 | Q4 2020 | 9 |
STE | STERIS CORP | 9 | 9 | 0.19% | 0.22% | 0.26% | Q4 2013 | Q4 2015 | 9 |
HOLX | HOLOGIC INC | 9 | 9 | 0.02% | 0.03% | 0.05% | Q3 2020 | Q3 2022 | 9 |
STKL | SUNOPTA INC | 8 | 8 | 0.12% | 1.26% | 3.12% | Q4 2013 | Q3 2015 | 8 |
XBI | SPDR S&P BIOTECH ETF | 6 | 2 | 0.22% | 0.48% | 1.70% | Q3 2016 | Q3 2021 | 8 |
IRIX | IRIDEX CORP | 5 | 3 | 0.06% | 0.35% | 0.71% | Q1 2016 | Q2 2018 | 8 |
SONENDO INC | 8 | 8 | 0.02% | 0.35% | 1.10% | Q3 2022 | Q2 2024 | 8 | |
CYH | COMMUNITY HEALTH SYS I... | 8 | 8 | 0.13% | 0.18% | 0.23% | Q4 2013 | Q3 2015 | 8 |
CVS | CVS HEALTH CORPORATION | 8 | 8 | 0.02% | 0.04% | 0.06% | Q4 2020 | Q3 2022 | 8 |
NVST | ENVISTA HOLDINGS CORPO... | 8 | 8 | 0.02% | 0.04% | 0.05% | Q4 2020 | Q3 2022 | 8 |
CI | CIGNA CORPORATION | 8 | 8 | 0.02% | 0.04% | 0.06% | Q4 2020 | Q3 2022 | 8 |
NUVA | NUVASIVE INC | 8 | 8 | 0.02% | 0.03% | 0.04% | Q4 2020 | Q3 2022 | 8 |
ICUI | ICU MED INC | 8 | 8 | 0.02% | 0.03% | 0.04% | Q4 2020 | Q3 2022 | 8 |
PRGO | PERRIGO CO PLC | 8 | 8 | 0.02% | 0.03% | 0.05% | Q4 2020 | Q3 2022 | 8 |
IG | IGI LABS INC | 7 | 7 | 2.61% | 4.22% | 7.81% | Q1 2014 | Q3 2015 | 7 |
MYOK | MYOKARDIA INC | 7 | 7 | 0.76% | 2.65% | 4.96% | Q1 2019 | Q3 2020 | 7 |
AMED | AMEDISYS INC | 7 | 7 | 1.80% | 2.44% | 3.58% | Q4 2015 | Q2 2017 | 7 |
FLDM | FLUIDIGM CORP DEL | 7 | 7 | 1.12% | 1.61% | 2.14% | Q4 2013 | Q2 2015 | 7 |
DVAX | DYNAVAX TECHNOLOGIES CORP | 7 | 7 | 0.50% | 1.50% | 2.13% | Q3 2017 | Q1 2019 | 7 |
NVTRQ | NUVECTRA CORP | 7 | 7 | 0.27% | 1.37% | 3.03% | Q1 2018 | Q3 2019 | 7 |
GMED | GLOBUS MEDICAL INC | 7 | 7 | 0.66% | 1.26% | 1.99% | Q3 2017 | Q1 2019 | 7 |
MEIP | MEI PHARMA INC | 7 | 7 | 0.24% | 1.22% | 2.14% | Q3 2020 | Q1 2022 | 7 |
CYTK | CYTOKINETICS INC COM | 7 | 7 | 0.40% | 0.69% | 1.03% | Q4 2013 | Q2 2015 | 7 |
NARI | INARI MEDICAL, INC. | 5 | 2 | 0.06% | 0.60% | 1.99% | Q3 2021 | Q2 2024 | 7 |
ABCM | ABCAM PLC | 7 | 7 | 0.36% | 0.58% | 1.36% | Q4 2021 | Q2 2023 | 7 |
GH | GUARDANT HEALTH INC | 7 | 7 | 0.30% | 0.53% | 1.06% | Q4 2022 | Q2 2024 | 7 |
PSCH | POWERSHARES S&P SMALLC... | 7 | 7 | 0.35% | 0.48% | 0.56% | Q4 2016 | Q2 2018 | 7 |
CNC | CENTENE CORPORATION | 5 | 1 | 0.03% | 0.11% | 0.52% | Q1 2020 | Q2 2024 | 7 |
STE | STERIS CORP | 4 | 3 | 0.03% | 0.11% | 0.23% | Q1 2016 | Q4 2019 | 7 |
WAT | WATERS CORPORATION | 7 | 7 | 0.03% | 0.04% | 0.06% | Q1 2021 | Q3 2022 | 7 |
ITGR | INTEGER HOLDINGS CORPO... | 7 | 7 | 0.03% | 0.04% | 0.05% | Q1 2021 | Q3 2022 | 7 |
SNN | SMITH & NEPHEW PLC SPO... | 5 | 2 | 0.03% | 0.03% | 0.04% | Q3 2019 | Q4 2023 | 7 |
MCK | MCKESSON CORP | 7 | 7 | 0.02% | 0.03% | 0.05% | Q1 2021 | Q3 2022 | 7 |
PKI | REVVITY INC | 5 | 1 | 0.02% | 0.03% | 0.04% | Q3 2018 | Q4 2023 | 7 |
GRFS | GRIFOLS SA SPONSORED A... | 7 | 7 | 0.01% | 0.03% | 0.04% | Q2 2019 | Q4 2020 | 7 |
XENE | XENON PHARMACEUTICALS INC | 6 | 6 | 0.90% | 3.13% | 6.10% | Q1 2023 | Q2 2024 | 6 |
GKOS | GLAUKOS CORPORATION | 6 | 6 | 0.48% | 2.59% | 3.78% | Q1 2020 | Q2 2021 | 6 |
NVDQ | NOVADAQ TECHNOLOGIES INC | 6 | 6 | 1.81% | 2.27% | 3.05% | Q4 2013 | Q1 2015 | 6 |
LCI | LANNET INC | 6 | 6 | 1.11% | 2.24% | 3.94% | Q4 2013 | Q1 2015 | 6 |
TCMD | TACTILE SYSTEMS TECHNO... | 6 | 6 | 1.04% | 2.19% | 3.29% | Q1 2023 | Q2 2024 | 6 |
STRO | SUTRO BIOPHARMA INC | 6 | 6 | 1.21% | 2.18% | 3.11% | Q4 2020 | Q1 2022 | 6 |
YMAB | Y-MABS THERAPEUTICS INC | 6 | 6 | 1.09% | 2.11% | 3.06% | Q2 2020 | Q3 2021 | 6 |
STAA | STAAR SURGICAL CO | 6 | 6 | 1.29% | 2.01% | 2.57% | Q4 2013 | Q1 2015 | 6 |
BLU | BELLUS HEALTH INC NEW | 6 | 6 | 1.34% | 1.96% | 2.59% | Q4 2021 | Q1 2023 | 6 |
CYNA | CYNAPSUS THERAPEUTICS INC | 6 | 6 | 1.15% | 1.83% | 2.41% | Q2 2015 | Q3 2016 | 6 |
DOC | PHYSICIANS RLTY TR | 6 | 6 | 1.27% | 1.72% | 2.40% | Q3 2015 | Q4 2016 | 6 |
REPH | SOCIETAL CDMO INC | 6 | 6 | 0.56% | 1.06% | 1.63% | Q4 2022 | Q1 2024 | 6 |
STEVANATO GROUP SPA | 6 | 6 | 0.27% | 1.05% | 2.06% | Q1 2023 | Q2 2024 | 6 | |
JYNT | THE JOINT CORP | 6 | 6 | 0.18% | 0.41% | 0.70% | Q4 2020 | Q1 2022 | 6 |
SIEN | SIENTRA INC | 6 | 6 | 0.14% | 0.30% | 0.60% | Q1 2021 | Q2 2022 | 6 |
GSK | GLAXOSMITHKLINE PLC | 6 | 6 | 0.03% | 0.04% | 0.06% | Q1 2021 | Q2 2022 | 6 |
GSK PLC | 6 | 6 | 0.03% | 0.03% | 0.04% | Q3 2022 | Q4 2023 | 6 | |
HCA | HCA HOLDINGS INC | 5 | 1 | 0.02% | 0.03% | 0.03% | Q3 2018 | Q4 2023 | 6 |
UHS | UNIVERSAL HEALTH SERVI... | 6 | 6 | 0.02% | 0.02% | 0.03% | Q1 2021 | Q2 2022 | 6 |
NVRO | NEVRO CORP | 5 | 5 | 1.44% | 2.16% | 3.17% | Q2 2017 | Q2 2018 | 5 |
ANAB | ANAPTYS BIO INC | 5 | 5 | 0.51% | 1.47% | 2.13% | Q2 2023 | Q2 2024 | 5 |
AMRN | AMARIN CORPORATION | 5 | 5 | 0.52% | 1.14% | 2.11% | Q3 2019 | Q3 2020 | 5 |
SGNT | SAGENT PHARMACEUTICALS... | 5 | 5 | 0.61% | 1.12% | 1.50% | Q4 2013 | Q4 2014 | 5 |
ZYME | ZYMEWORKS INC | 5 | 5 | 0.25% | 0.95% | 2.00% | Q1 2020 | Q1 2021 | 5 |
NSTG | NANOSTRING TECHNOLOGIE... | 5 | 5 | 0.64% | 0.87% | 1.14% | Q2 2016 | Q2 2017 | 5 |
TRUP | TRUPANION INC | 5 | 5 | 0.74% | 0.85% | 0.98% | Q4 2018 | Q4 2019 | 5 |
ITMR | ITAMAR MEDICAL LTD | 4 | 1 | 0.16% | 0.74% | 1.32% | Q1 2020 | Q4 2021 | 5 |
ALXN | ALEXION PHARMACEUTICAL... | 4 | 1 | 0.07% | 0.64% | 1.88% | Q2 2019 | Q4 2020 | 5 |
MRVI | MARAVAI LIFESCIENCES H... | 5 | 5 | 0.29% | 0.62% | 1.16% | Q4 2020 | Q4 2021 | 5 |
MGNX | MACROGENICS INC | 5 | 5 | 0.36% | 0.52% | 0.89% | Q4 2016 | Q4 2017 | 5 |
MYL | MYLAN LABS INC | 5 | 5 | 0.30% | 0.33% | 0.36% | Q4 2013 | Q4 2014 | 5 |
CFN | CAREFUSION CORP | 5 | 5 | 0.22% | 0.24% | 0.26% | Q4 2013 | Q4 2014 | 5 |
FMS | FRESENIUS MEDICAL CARE... | 5 | 5 | 0.03% | 0.04% | 0.04% | Q4 2022 | Q4 2023 | 5 |
ENOVIS CORPORATION | 5 | 5 | 0.03% | 0.04% | 0.04% | Q4 2022 | Q4 2023 | 5 | |
EXEL | EXELIXIS INC | 5 | 5 | 0.03% | 0.03% | 0.04% | Q4 2022 | Q4 2023 | 5 |
QUIDELORTHO CORP | 5 | 5 | 0.02% | 0.03% | 0.03% | Q4 2022 | Q4 2023 | 5 | |
IART | INTEGRA LIFESCIENCES H... | 5 | 5 | 0.02% | 0.03% | 0.04% | Q4 2022 | Q4 2023 | 5 |
VTRS | VIATRIS INC | 5 | 5 | 0.03% | 0.03% | 0.03% | Q4 2022 | Q4 2023 | 5 |
MDT | MEDTRONIC PLC | 5 | 5 | 0.03% | 0.03% | 0.03% | Q4 2022 | Q4 2023 | 5 |
BAYRY | BAYER AG SPONSORED ADR | 5 | 5 | 0.02% | 0.03% | 0.04% | Q4 2022 | Q4 2023 | 5 |
QGEN | QIAGEN NV | 5 | 5 | 0.02% | 0.03% | 0.03% | Q4 2022 | Q4 2023 | 5 |
XRAY | DENTSPLY SIRONA INC | 5 | 5 | 0.02% | 0.03% | 0.03% | Q4 2022 | Q4 2023 | 5 |
BIIB | BIOGEN INC | 5 | 5 | 0.02% | 0.03% | 0.03% | Q4 2022 | Q4 2023 | 5 |
LH | LABORATORY CORPORATION... | 5 | 5 | 0.02% | 0.02% | 0.03% | Q4 2022 | Q4 2023 | 5 |
PDCO | PATTERSON COS INC | 5 | 5 | 0.02% | 0.02% | 0.03% | Q4 2022 | Q4 2023 | 5 |
OGN | ORGANON & CO | 5 | 5 | 0.02% | 0.02% | 0.03% | Q4 2022 | Q4 2023 | 5 |
RETA | REATA PHARMACEUTICALS INC | 4 | 4 | 2.68% | 8.60% | 12.99% | Q3 2022 | Q2 2023 | 4 |
ARWR | ARROWHEAD PHARMACEUTIC... | 4 | 4 | 1.28% | 2.49% | 4.00% | Q3 2020 | Q2 2021 | 4 |
SAGE | SAGE THERAPEUTICS INC | 4 | 4 | 1.86% | 2.25% | 2.54% | Q3 2016 | Q2 2017 | 4 |
SPPI | SPECTRUM PHARMACEUTICA... | 4 | 4 | 0.74% | 1.70% | 2.11% | Q1 2014 | Q4 2014 | 4 |
TELA | TELA BIO INC | 4 | 4 | 1.20% | 1.45% | 1.88% | Q2 2023 | Q1 2024 | 4 |
BIOS | BIOSCRIPT INC | 4 | 4 | 0.21% | 1.41% | 2.64% | Q4 2015 | Q3 2016 | 4 |
ABCO | ADVISORY BRD CO | 4 | 4 | 1.16% | 1.36% | 1.54% | Q4 2013 | Q3 2014 | 4 |
NGM | NGM BIOPHARMACEUTICALS... | 4 | 4 | 0.72% | 1.20% | 1.69% | Q4 2021 | Q3 2022 | 4 |
ALGN | ALIGN TECHNOLOGY INC | 4 | 4 | 1.15% | 1.19% | 1.25% | Q1 2014 | Q4 2014 | 4 |
ADRO | ADURO BIOTECH INC | 4 | 4 | 0.40% | 1.14% | 1.87% | Q4 2018 | Q3 2019 | 4 |
BVS | BIOVENTUS INC | 4 | 4 | 0.33% | 0.88% | 1.12% | Q1 2022 | Q4 2022 | 4 |
APTOSE BIOSCIENCES INC | 4 | 4 | 0.27% | 0.73% | 1.23% | Q4 2020 | Q3 2021 | 4 | |
EPZM | EPIZYME INC | 4 | 4 | 0.31% | 0.45% | 0.62% | Q2 2019 | Q1 2020 | 4 |
CSTL | CASTLE BIOSCIENCES INC | 4 | 4 | 0.17% | 0.32% | 0.43% | Q3 2022 | Q2 2023 | 4 |
V107SC | WELLPOINT INC | 4 | 4 | 0.29% | 0.31% | 0.34% | Q4 2013 | Q3 2014 | 4 |
CLLS | CELLECTIS SA | 4 | 4 | 0.07% | 0.19% | 0.35% | Q3 2018 | Q2 2019 | 4 |
AGRX | AGILE THERAPEUTICS | 4 | 4 | 0.11% | 0.16% | 0.21% | Q1 2016 | Q4 2016 | 4 |
TFX | TELEFLEX INCORPORATED | 4 | 4 | 0.03% | 0.03% | 0.03% | Q2 2018 | Q1 2019 | 4 |
UNH | UNITEDHEALTH GROUP INC | 3 | 1 | 0.02% | 0.03% | 0.04% | Q4 2019 | Q4 2020 | 4 |
OFIX | ORTHOFIX MED INC | 3 | 3 | 2.26% | 3.25% | 4.00% | Q1 2023 | Q3 2023 | 3 |
NTRA | NATERA INC | 3 | 3 | 0.84% | 2.98% | 4.60% | Q4 2023 | Q2 2024 | 3 |
OFIX | ORTHOFIX INTERNATIONAL NV | 3 | 3 | 1.78% | 2.29% | 2.55% | Q1 2016 | Q3 2016 | 3 |
TECH | TECHNE CORP | 3 | 3 | 2.05% | 2.21% | 2.34% | Q1 2014 | Q3 2014 | 3 |
ALDX | ALDEYRA THERAPEUTICS INC | 3 | 3 | 1.73% | 2.05% | 2.36% | Q1 2021 | Q3 2021 | 3 |
EVHC | ENVISION HEALTHCARE HO... | 3 | 3 | 1.45% | 2.03% | 2.37% | Q4 2015 | Q2 2016 | 3 |
LDRH | LDR HOLDING CORPORATION | 3 | 3 | 1.81% | 2.00% | 2.31% | Q4 2015 | Q2 2016 | 3 |
R1 RCM INC | 3 | 3 | 0.69% | 1.98% | 2.71% | Q4 2023 | Q2 2024 | 3 | |
IRTC | IRHYTHM TECHNOLOGIES | 3 | 3 | 0.79% | 1.95% | 3.74% | Q3 2023 | Q1 2024 | 3 |
OSCR | OSCAR HEALTH INC CLASS A | 3 | 3 | 0.71% | 1.90% | 2.59% | Q4 2023 | Q2 2024 | 3 |
P103PS | NPS PHARMACEUTICALS INC | 3 | 3 | 1.68% | 1.76% | 1.86% | Q4 2013 | Q2 2014 | 3 |
BEAT | BIOTELEMETRY INC | 3 | 3 | 0.76% | 1.61% | 2.15% | Q1 2016 | Q3 2016 | 3 |
ELGXQ | ENDOLOGIX INC | 3 | 3 | 0.58% | 1.59% | 2.48% | Q2 2019 | Q4 2019 | 3 |
STRUCTURE THERAPEUTICS... | 2 | 1 | 0.49% | 1.44% | 2.03% | Q3 2023 | Q2 2024 | 3 | |
TRHC | TABULA RASA HEALTHCARE... | 3 | 3 | 1.20% | 1.37% | 1.62% | Q3 2019 | Q1 2020 | 3 |
INSP | INSPIRE MEDICAL SYSTEM... | 3 | 3 | 0.33% | 1.36% | 2.30% | Q4 2023 | Q2 2024 | 3 |
ARWR | ARROWHEAD RESH CORP | 3 | 3 | 1.19% | 1.24% | 1.32% | Q3 2015 | Q1 2016 | 3 |
GNMK | GENMARK DIAGNOSTICS INC | 3 | 3 | 0.99% | 1.23% | 1.37% | Q4 2013 | Q2 2014 | 3 |
EVH | EVOLENT HEALTH INC | 3 | 3 | 0.22% | 1.12% | 2.42% | Q4 2023 | Q2 2024 | 3 |
STIM | NEURONETICS INC | 3 | 3 | 0.63% | 0.99% | 1.41% | Q1 2021 | Q3 2021 | 3 |
F113PS | COVIDIEN PLC | 3 | 3 | 0.84% | 0.94% | 1.09% | Q4 2013 | Q2 2014 | 3 |
GBT | GLOBAL BLOOD THERAPEUT... | 3 | 3 | 0.10% | 0.80% | 2.16% | Q4 2019 | Q2 2020 | 3 |
TCRR | TCR2 THERAPEUTICS INC | 3 | 3 | 0.35% | 0.73% | 1.21% | Q1 2021 | Q3 2021 | 3 |
MIRM | MIRUM PHARMACEUTICALS INC | 3 | 3 | 0.42% | 0.72% | 1.11% | Q1 2022 | Q3 2022 | 3 |
JAZZ | JAZZ PHARMACEUTICALS PLC | 3 | 3 | 0.58% | 0.66% | 0.75% | Q3 2020 | Q1 2021 | 3 |
SURG | SYNERGETICS USA INC | 3 | 3 | 0.48% | 0.60% | 0.72% | Q4 2013 | Q2 2014 | 3 |
NVTA | INVITAE CORPORATION | 3 | 3 | 0.48% | 0.55% | 0.64% | Q1 2021 | Q3 2021 | 3 |
DYN | DYNE THERAPEUTICS INC | 2 | 1 | 0.05% | 0.49% | 1.18% | Q3 2020 | Q2 2024 | 3 |
FRX | FOREST LABS INC | 3 | 3 | 0.39% | 0.43% | 0.50% | Q4 2013 | Q2 2014 | 3 |
ANNX | ANNEXON BIOSCIENCES INC | 3 | 3 | 0.28% | 0.42% | 0.59% | Q2 2021 | Q4 2021 | 3 |
B108PS | ACTAVIS PLC | 3 | 3 | 0.30% | 0.31% | 0.34% | Q3 2014 | Q1 2015 | 3 |
CEMI | CHEMBIO DIAGNOSTICS INC | 3 | 3 | 0.11% | 0.20% | 0.25% | Q3 2016 | Q1 2017 | 3 |
IWO | ISHARES RUSSELL 2000 G... | 1 | 1 | 0.07% | 0.17% | 0.32% | Q2 2022 | Q4 2023 | 3 |
EBS | EMERGENT BIOSOLUTIONS INC | 3 | 3 | 0.01% | 0.02% | 0.03% | Q1 2021 | Q3 2021 | 3 |
CNTA | CENTESSA PHARMACEUTICA... | 2 | 2 | 2.60% | 3.19% | 3.78% | Q1 2024 | Q2 2024 | 2 |
PTLA | PORTOLA PHARMACEUTICAL... | 2 | 2 | 3.08% | 3.09% | 3.10% | Q3 2019 | Q4 2019 | 2 |
SWAV | SHOCKWAVE MEDICAL INC | 2 | 2 | 1.83% | 2.93% | 4.03% | Q4 2023 | Q1 2024 | 2 |
PFNX | PFENEX INC | 2 | 2 | 2.28% | 2.90% | 3.52% | Q1 2020 | Q2 2020 | 2 |
PODD | INSULET CORP | 2 | 2 | 1.98% | 2.90% | 3.82% | Q1 2024 | Q2 2024 | 2 |
AERI | AERIE PHARMACEUTICALS INC | 2 | 2 | 1.96% | 2.44% | 2.93% | Q1 2019 | Q2 2019 | 2 |
AMAG | AMAG PHARMACEUTICALS INC | 2 | 2 | 1.14% | 2.41% | 3.68% | Q1 2015 | Q2 2015 | 2 |
VERA | VERA THERAPEUTICS INC | 2 | 2 | 1.44% | 2.32% | 3.19% | Q1 2024 | Q2 2024 | 2 |
LIVN | LIVANOVA PLC | 2 | 2 | 0.44% | 1.93% | 3.41% | Q1 2024 | Q2 2024 | 2 |
AGIO | AGIOS PHARMACEUTICALS INC | 2 | 2 | 1.63% | 1.67% | 1.72% | Q2 2019 | Q3 2019 | 2 |
ZNTL | ZENTALIS PHARMACEUTICA... | 2 | 2 | 1.62% | 1.65% | 1.68% | Q2 2023 | Q3 2023 | 2 |
OM | OUTSET MEDICAL INC | 2 | 2 | 1.06% | 1.07% | 1.09% | Q2 2023 | Q3 2023 | 2 |
IDYA | IDEAYA BIOSCIENCES INC | 2 | 2 | 0.99% | 1.06% | 1.13% | Q4 2023 | Q1 2024 | 2 |
MASI | MASIMO CORP | 2 | 2 | 1.00% | 1.05% | 1.11% | Q4 2013 | Q1 2014 | 2 |
VSTM | VERASTEM INC | 2 | 2 | 0.81% | 0.95% | 1.08% | Q1 2015 | Q2 2015 | 2 |
THC | TENET HEALTHCARE CORP | 2 | 2 | 0.64% | 0.91% | 1.18% | Q4 2023 | Q1 2024 | 2 |
ISIS | ISIS PHARMACEUTICALS INC | 2 | 2 | 0.72% | 0.88% | 1.03% | Q3 2014 | Q4 2014 | 2 |
OREX | OREXIGEN THERAPEUTICS INC | 2 | 2 | 0.82% | 0.86% | 0.90% | Q4 2013 | Q1 2014 | 2 |
KPTI | KARYOPHARM THERAPEUTIC... | 2 | 2 | 0.80% | 0.83% | 0.85% | Q3 2015 | Q4 2015 | 2 |
ADVM | ADVERIUM BIOTECHNOLOGI... | 2 | 2 | 0.40% | 0.77% | 1.14% | Q1 2020 | Q2 2020 | 2 |
HTWR | HEARTWARE INTL INC | 2 | 2 | 0.70% | 0.71% | 0.72% | Q4 2013 | Q1 2014 | 2 |
BTAI | BIOXCEL THERAPEUTICS INC | 2 | 2 | 0.32% | 0.67% | 1.03% | Q4 2020 | Q1 2021 | 2 |
PEN | PENUMBRA, INC. | 2 | 2 | 0.65% | 0.66% | 0.68% | Q1 2024 | Q2 2024 | 2 |
ESPR | ESPERION THERAPEUTICS ... | 2 | 2 | 0.56% | 0.66% | 0.77% | Q2 2015 | Q3 2015 | 2 |
THOR | THORATEC CORP | 2 | 2 | 0.61% | 0.64% | 0.67% | Q4 2013 | Q1 2014 | 2 |
VVUS | VIVUS INC | 2 | 2 | 0.49% | 0.62% | 0.75% | Q4 2013 | Q1 2014 | 2 |
PCVX | VAXCYTE INC | 2 | 2 | 0.32% | 0.62% | 0.92% | Q1 2024 | Q2 2024 | 2 |
SGMO | SANGAMO THERAPEUTICS INC | 2 | 2 | 0.34% | 0.54% | 0.73% | Q2 2018 | Q3 2018 | 2 |
RLAY | RELAY THERAPEUTICS INC | 2 | 2 | 0.11% | 0.48% | 0.86% | Q2 2021 | Q3 2021 | 2 |
MRTX | MIRATI THERAPEUTICS INC | 2 | 2 | 0.33% | 0.45% | 0.58% | Q4 2021 | Q1 2022 | 2 |
TEAR | TEARLAB CORP | 2 | 2 | 0.24% | 0.35% | 0.46% | Q1 2017 | Q2 2017 | 2 |
MASS | 908 DEVICES INC | 2 | 2 | 0.07% | 0.20% | 0.34% | Q4 2020 | Q1 2021 | 2 |
RPHM | RENEO PHARMACEUTICALS INC | 2 | 2 | 0.13% | 0.16% | 0.20% | Q2 2023 | Q3 2023 | 2 |
AVGR | AVINGER INC | 2 | 2 | 0.07% | 0.14% | 0.20% | Q3 2016 | Q4 2016 | 2 |
GWPH | GW PHARMACEUTICALS PLC | 2 | 2 | 0.07% | 0.08% | 0.10% | Q1 2020 | Q2 2020 | 2 |
TMO | THERMO FISHER SCIENTIF... | 2 | 2 | 0.03% | 0.03% | 0.03% | Q1 2019 | Q2 2019 | 2 |
AKORN INC | 1 | 1 | 3.60% | 3.60% | 3.60% | Q4 2013 | Q4 2013 | 1 | |
5100PS | VOLCANO CORPORATION | 1 | 1 | 2.81% | 2.81% | 2.81% | Q4 2013 | Q4 2013 | 1 |
IOVA | IOVANCE BIOTHERAPEUTIC... | 1 | 1 | 2.71% | 2.71% | 2.71% | Q1 2020 | Q1 2020 | 1 |
ACCL | ACCELRYS INC | 1 | 1 | 2.53% | 2.53% | 2.53% | Q4 2013 | Q4 2013 | 1 |
VCRA | VOCERA COMMUNICATIONS INC | 1 | 1 | 2.40% | 2.40% | 2.40% | Q2 2014 | Q2 2014 | 1 |
FPRX | FIVE PRIME THERAPEUTIC... | 1 | 1 | 1.97% | 1.97% | 1.97% | Q4 2020 | Q4 2020 | 1 |
VNDA | VANDA PHARMACEUTICALS INC | 1 | 1 | 1.86% | 1.86% | 1.86% | Q4 2014 | Q4 2014 | 1 |
HGEN | HUMANIGEN INC | 1 | 1 | 1.80% | 1.80% | 1.80% | Q2 2020 | Q2 2020 | 1 |
MDVN | MEDIVATION INC | 1 | 1 | 1.70% | 1.70% | 1.70% | Q4 2015 | Q4 2015 | 1 |
PRVA | PRIVIA HEALTH GROUP INC | 1 | 1 | 1.66% | 1.66% | 1.66% | Q1 2024 | Q1 2024 | 1 |
ALPN | ALPINE IMMUNE SCIENCES... | 1 | 1 | 1.52% | 1.52% | 1.52% | Q1 2024 | Q1 2024 | 1 |
ARTHROCARE CORP | 1 | 1 | 1.50% | 1.50% | 1.50% | Q4 2013 | Q4 2013 | 1 | |
HZNP | HORIZON PHARMA PLC | 1 | 1 | 1.45% | 1.45% | 1.45% | Q4 2022 | Q4 2022 | 1 |
BIOHAVEN LTD | 1 | 1 | 1.32% | 1.32% | 1.32% | Q4 2023 | Q4 2023 | 1 | |
ALIGN TECHNOLOGY INC | 1 | 1 | 1.31% | 1.31% | 1.31% | Q4 2013 | Q4 2013 | 1 | |
SLXP | SALIX PHARMACEUTICALS INC | 1 | 1 | 1.14% | 1.14% | 1.14% | Q4 2014 | Q4 2014 | 1 |
ITMN | INTERMUNE INC | 1 | 1 | 1.04% | 1.04% | 1.04% | Q2 2014 | Q2 2014 | 1 |
OSUR | ORASURE TECHNOLOGIES INC | 1 | 1 | 0.95% | 0.95% | 0.95% | Q4 2018 | Q4 2018 | 1 |
OLMA | OLEMA PHARMACEUTICALS INC | 1 | 1 | 0.71% | 0.71% | 0.71% | Q4 2023 | Q4 2023 | 1 |
SVRA | SAVARA INC | 1 | 1 | 0.71% | 0.71% | 0.71% | Q2 2024 | Q2 2024 | 1 |
LABU | DIREXION DAILY S&P BIO... | 1 | 1 | 0.61% | 0.61% | 0.61% | Q3 2022 | Q3 2022 | 1 |
WW | WW INTERNATIONAL INC | 1 | 1 | 0.55% | 0.55% | 0.55% | Q3 2021 | Q3 2021 | 1 |
ENDP | ENDO HEALTH SOLUTIONS INC | 1 | 1 | 0.52% | 0.52% | 0.52% | Q4 2013 | Q4 2013 | 1 |
EXAS | EXACT SCIENCES CORP | 1 | 1 | 0.46% | 0.46% | 0.46% | Q2 2024 | Q2 2024 | 1 |
HGEN | HUMANIGEN INC | 1 | 1 | 0.44% | 0.44% | 0.44% | Q3 2020 | Q3 2020 | 1 |
ASND | ASCENDIS PHARMA A/S | 1 | 1 | 0.43% | 0.43% | 0.43% | Q2 2024 | Q2 2024 | 1 |
FIXX | HOMOLOGY MEDICINES INC. | 1 | 1 | 0.39% | 0.39% | 0.39% | Q3 2019 | Q3 2019 | 1 |
ASTRAZENECA PLC | 1 | 1 | 0.29% | 0.29% | 0.29% | Q4 2013 | Q4 2013 | 1 | |
VENTYX BIOSCIENCES INC | 1 | 1 | 0.26% | 0.26% | 0.26% | Q1 2024 | Q1 2024 | 1 | |
BECTON DICKINSON & CO | 1 | 1 | 0.26% | 0.26% | 0.26% | Q4 2013 | Q4 2013 | 1 | |
INVESCO SMALLCAP HEALT... | 1 | 1 | 0.26% | 0.26% | 0.26% | Q1 2019 | Q1 2019 | 1 | |
NNOX | NANO X IMAGING LTD | 1 | 1 | 0.25% | 0.25% | 0.25% | Q3 2020 | Q3 2020 | 1 |
AMGEN INC | 1 | 1 | 0.23% | 0.23% | 0.23% | Q4 2013 | Q4 2013 | 1 | |
IRMD | IRADIMED CORP | 1 | 1 | 0.19% | 0.19% | 0.19% | Q4 2016 | Q4 2016 | 1 |
BIO RAD LABS INC | 1 | 1 | 0.18% | 0.18% | 0.18% | Q4 2013 | Q4 2013 | 1 | |
RMED | RA Medical Systems, Inc. | 1 | 1 | 0.18% | 0.18% | 0.18% | Q3 2018 | Q3 2018 | 1 |
QTRX | QUANTERIX CORPORATION | 1 | 1 | 0.10% | 0.10% | 0.10% | Q1 2021 | Q1 2021 | 1 |
FATE | FATE THERAPEUTICS INC | 1 | 1 | 0.08% | 0.08% | 0.08% | Q2 2021 | Q2 2021 | 1 |
SRPT | SAREPTA THERAPEUTICS INC. | 1 | 1 | 0.06% | 0.06% | 0.06% | Q2 2019 | Q2 2019 | 1 |
TXG | 10X GENOMICS INC CLASS A | 1 | 1 | 0.04% | 0.04% | 0.04% | Q3 2019 | Q3 2019 | 1 |
LABD | DIREXION DAILY S&P BIO... | 1 | 1 | 0.04% | 0.04% | 0.04% | Q1 2020 | Q1 2020 | 1 |
DHR | DANAHER CORP | 1 | 1 | 0.03% | 0.03% | 0.03% | Q2 2019 | Q2 2019 | 1 |
HALEON PLC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2022 | Q3 2022 | 1 | |
Download |
The securities at the top of the list , including ATRICURE INC, NEOGENOMICS INC, and SANOFI-SYNTHELABO, are the highest-conviction holdings of First Light Asset Management, LLC.
The conviction is calculated by counting the number of quarters a security has been reported by First Light Asset Management, LLC. The higher the number, the higher the conviction and longer the holding period.
This page lists all the securities that First Light Asset Management, LLC owns currently or has owned in the past.